a Cs 5 SiFe(OH 2 )W 11 o 39 ·6H 2 The preparation method of O sustained and controlled release capsule is based on Cs 5 SiFe(OH 2 )W 11 o 39 ·6H 2 O as raw material, lactose, ethyl cellulose, hypromellose, silicon dioxide, montmorillonite, sodium chloride, cellulose acetate, dibutyl phthalate, simethicone, magnesium stearate , sodium bisulfite, and sodium lauryl sulfate are used as auxiliary materials, which are respectively prepared by slow-release pellets, wrapped by an adsorption water diversion layer, wrapped by a controlled-release coating layer, and finally filled with capsules; Uniform, can achieve controlled release, the average release rate in the in vitro release test is 10% to 15% every 2 hours, compared with traditional controlled and sustained release preparations, the release is more uniform, the constant release rate is nearly 14 hours, the shelf life of this product Long, up to 24 months, the impurity increase is small during the storage process, and the impurity increase is only 0.13% after 24 months of storage. The invention has high anti-tumor activity, low toxicity, and low price, and can be used for human liver cancer cells (HepG‑2) , human lung cancer cells (A549), human breast cancer cells (MCF‑7), and human colon cancer cells (CT26, HT29).